MIF/CD74 axis is a target for metformin therapy in diabetic podocytopathy - real world evidence. [electronic resource]
Producer: 20181031Description: 264-268 p. digitalISSN:- 2299-8306
- Adult
- Antigens, Differentiation, B-Lymphocyte -- blood
- Blood Glucose -- analysis
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies -- blood
- Drug Therapy, Combination
- Female
- Glycated Hemoglobin -- analysis
- Histocompatibility Antigens Class II -- blood
- Humans
- Intramolecular Oxidoreductases -- blood
- Macrophage Migration-Inhibitory Factors -- blood
- Male
- Metformin -- pharmacology
- Middle Aged
- Podocytes
- Protective Agents -- pharmacology
- Sialoglycoproteins -- urine
- Sulfonylurea Compounds
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.